Obesity leaves methylation marks in eggs that reprogram offspring metabolism

One of the most troubling patterns in modern medicine is that children born to mothers with obesity face elevated risks of diabetes, fatty liver disease and cardiovascular problems long before they make their own lifestyle choices. Epidemiological studies have documented this transmission for decades, and animal experiments have repeatedly shown that metabolic dysfunction can pass from mother to offspring even when the young are carried by healthy surrogate mothers. What has remained stubbornly elusive is the molecular mechanism: how does a mother’s metabolic state write a lasting message into her eggs, and how does that message survive the wholesale epigenetic erasure that embryos normally undergo? A new study published in Nature Metabolism by Longsen Han, Yiqiu Wu, Jiashuo Li, Yujia Chen, Ling Li, Teng Wang and colleagues, led by Qiang Wang of Nanjing Medical University, now provides the most direct answer yet, and it is a striking one.

The research team began by asking a fundamental question about the egg itself. Oocytes, the precursors of eggs, carry their own DNA methylome, a landscape of methyl groups attached to cytosine bases that helps regulate which genes are active. When the researchers compared oocytes from mice fed a high-fat diet with oocytes from normally fed mice, they found nearly 940 differentially methylated regions, many of them sitting at genes with well-established roles in metabolism. Crucially, the changes were not random noise scattered across the genome. They clustered at specific regulatory loci, including regions controlling Hnf1α, a transcription factor that governs liver and pancreatic gene programs; Thra, encoding a thyroid hormone receptor involved in hepatic insulin sensitivity; and Pdk4, a kinase that suppresses glucose oxidation in favor of fat burning. These were precisely the kinds of genes whose misregulation could plausibly produce the metabolic phenotypes seen in offspring of obese mothers.

The next question was whether these methylation changes actually persist into the next generation, and here the study produced some of its most surprising findings. Embryos are known to undergo dramatic epigenetic reprogramming: shortly after fertilization, most DNA methylation across the genome is erased and then rebuilt anew, a process thought to wipe the slate clean between generations. The team tracked the methylation status of the obesity-associated regions through blastocysts, primordial germ cells and the tissues of first- and second-generation offspring. The methylation marks themselves were indeed erased during embryogenesis, exactly as the textbooks predict. Yet the genes did not return to normal. Hnf1α, Thra and Pdk4 showed persistent transcriptional dysregulation across two generations, and the methylation patterns re-emerged at the same loci in the germline of the next generation of females, suggesting that something other than the methyl marks themselves was carrying the memory forward.

That something, the researchers discovered, appears to be a histone modification. At the affected loci, enrichment of H3K36me2, a chemical tag on histone proteins that is known to recruit the de novo DNA methyltransferases in oocytes, was retained even after the DNA methylation had been stripped away. In other words, the embryo erased the methyl letters but kept the highlighted page. When the oocytes of the next generation were formed, the H3K36me2 signal guided the methylation machinery back to the same spots, re-establishing the aberrant pattern. This chromatin-based bookmark offers a mechanistic explanation for how environmental information can tunnel through the reprogramming barrier, and it aligns with earlier work showing that H3K36me2 and its trimerized cousin H3K36me3 form a platform essential for DNA methylation establishment in mouse oocytes.

To connect specific methylation changes to specific metabolic outcomes, the team turned to an elegant set of experiments using methylation editing. Rather than relying on diet to produce diffuse, genome-wide changes, they injected in vitro-matured oocytes with a catalytically dead Cas9 fused to the methyltransferase Dnmt3a, together with guide RNAs targeting single differentially methylated regions. This allowed them to hypermethylate one locus at a time and ask what each mark does on its own. The results were remarkably clean. Offspring derived from oocytes with targeted hypermethylation at the Hnf1α region showed enhanced hepatic gluconeogenesis, meaning their livers produced more glucose, while offspring with engineered hypermethylation at the Pdk4 region displayed impaired glucose tolerance. Both effects were female-biased, echoing the sex-specific patterns seen in the diet-induced model, and both persisted into the second generation when the edited females were bred onward.

The sex specificity is itself an important clue. Female offspring carried the metabolic consequences far more prominently than males, and methylation analyses across liver, kidney, brain and muscle showed that the aberrant marks were established in a tissue-specific pattern rather than uniformly across the body. The researchers also found that single CpG sites within the differentially methylated regions acted as regulatory landmarks correlating with gene expression, providing fine-grained markers that could eventually be used to read the epigenetic state of a locus without sequencing entire regions. This level of resolution matters because it moves the field from correlational observations, where obese mothers tend to have affected offspring, toward a causal, mechanistic account in which defined chemical marks at defined genes produce defined phenotypes.

Perhaps the most consequential finding for human medicine came when the team examined oocytes donated by women undergoing fertility treatment. In oocytes from women with obesity, the researchers detected conserved hypermethylation at the same HNF1A and THRA loci that had been flagged in the mouse studies. The convergence is striking: two species separated by tens of millions of years of evolution, exposed to obesity through very different diets and environments, show methylation changes at homologous metabolic genes. While the human sample cannot prove causation, the conservation of the pattern strongly suggests that the mechanism identified in mice is not a laboratory artifact but a feature of mammalian biology that operates in people.

The study builds on a growing body of evidence that the germline is a conduit for environmental memory. Earlier work has shown that sperm carry small RNAs that transmit acquired metabolic disorders to offspring, that paternal diet shapes offspring chromatin states, and that oocyte deficiencies in factors such as Stella and TET3 can transmit glucose intolerance from obese mothers to their young. What distinguishes the new research is its combination of genome-wide mapping across generations, identification of a chromatin-based persistence mechanism, and direct causal demonstration through targeted methylation editing. Together these threads turn a suggestive correlation into a coherent causal chain: maternal obesity alters the oocyte methylome at metabolic loci, H3K36me2 bookmarks those loci through embryonic reprogramming, methylation is re-established in the next generation’s germline, and the resulting gene dysregulation produces measurable metabolic dysfunction in offspring, preferentially in females.

The implications reach well beyond the laboratory. If the preconception oocyte is the critical window during which these marks are laid down, then interventions aimed at improving metabolic health before pregnancy, rather than during it, may carry particular weight for breaking the intergenerational cycle of obesity and diabetes. The finding that methylation marks are erased but re-established also suggests potential targets: if the H3K36me2 bookmarking step could be understood in finer detail, it might eventually become possible to interrupt the re-establishment of pathological marks without touching the normal reprogramming program. The authors caution that much work remains, including determining how broadly the mechanism applies across loci and confirming the human findings at scale. But the central message is already clear and, for a condition affecting hundreds of millions of people worldwide, sobering: the metabolic consequences of obesity can be written into the egg itself, in the language of DNA methylation, and read out again in the bodies of children and grandchildren.

Subject of Research: Intergenerational epigenetic inheritance of metabolic dysfunction via oocyte DNA methylation in maternal obesity

Article Title: Maternal obesity imprints methylation marks in oocytes to drive intergenerational metabolic dysfunction

Article References: Han, L., Wu, Y., Li, J., Chen, Y., Li, L., Wang, T., Chen, M., Wang, S., Li, C., Ding, G., Li, J., Sun, H., Shi, Z., & Wang, Q. (2026). Maternal obesity imprints methylation marks in oocytes to drive intergenerational metabolic dysfunction. Nature Metabolism. https://doi.org/10.1038/s42255-026-01617-6

Image Credits: AI Generated

DOI: 10.1038/s42255-026-01617-6

Keywords: maternal obesity, oocytes, DNA methylation, epigenetic inheritance, H3K36me2, Hnf1α, Pdk4, Thra, glucose metabolism, methylation editing, Nature Metabolism, intergenerational metabolic dysfunction